8BE-32498-90881
2 vaccinations
6 coded responses
26 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-11
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-13
Registered in v-safe
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Premature ovulation — Feeling: Good · Headache, Muscle or body achesFree text: Earlier than normal ovulationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-17
- 2021-04-18
-
2021-04-25
Survey response — day 14, dose 1MedDRA: Herpes zoster, Rash — Feeling: FairFree text: A rash on my face, on the same side as I got the vaccine. Possible shingles.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — day 21, single doseMedDRA: Herpes simplex — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 2 weeks after the vaccination, I developed a herpes simplex 1 outbreak on the same side of my face as I got the vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Report sent to call center — day 21, single doseGet care from a doctor or other healthcare professional1 call case(s)
- 2021-05-09
- 2021-05-16
- 2021-05-23
-
2021-05-28
Call successfulParticipant prefers to complete VAERS report online
- 2021-07-11
- 2021-10-10
-
2021-12-05
Dose 2 — Moderna
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-12
-
2021-12-19
Survey response — day 14, dose 2MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with gestational diabetes, probably not related.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-20
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-26
- 2022-01-02
- 2022-01-09
- 2022-01-16
-
2022-03-06
Survey response — 3 months, dose 2MedDRA: Postpartum state, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Postpartum onset preeclampsia after delivering babyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-03-08
- 2022-06-05
-
2022-12-05
Survey response — 12 months, dose 2MedDRA: COVID-19, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had COVID and later RSV.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-06
- 2022-12-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-05 | Moderna | No |
Call center
4 call center cases
2 successful · 2 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Earlier than normal ovulation
Release 7 — day 14, dose 1
Symptoms: A rash on my face, on the same side as I got the vaccine. Possible shingles.
Release 8 — day 21, single dose
Symptoms: 2 weeks after the vaccination, I developed a herpes simplex 1 outbreak on the same side of my face as I got the vaccine.
Release 10 — day 14, dose 2
Symptoms: Diagnosed with gestational diabetes, probably not related.
Release 11 — 3 months, dose 2
Symptoms: Postpartum onset preeclampsia after delivering baby
Release 12 — 12 months, dose 2
Symptoms: I had COVID and later RSV.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
| SD | Herpes simplex | ✓ | ✓ | ✓ |
| SD | Herpes zoster | ✓ | ✓ | ✓ |
| SD | Postpartum state | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SRO | Premature ovulation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release